300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology Startup Investors in Middle East (October 2026)

The most active venture capital funds and angel investors investing in Middle East Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Middle East Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Trendlines Group
VC Fund
21 Israel, Singapore, United Kingdom Seed, Venture - Series Unknown Health Care, Biotechnology, Medical Device $650k–$62M
Israel Innovation Authority
VC Fund
18 Israel, United States, Mali Grant, Seed, Pre-Seed Health Care, Artificial Intelligence, Biotechnology $100k–$6M
Pontifax
VC Fund
16 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6.3M–$130M
OurCrowd
VC Fund
16 Israel, United States, New Zealand Series B, Series A, Seed Software, Artificial Intelligence, Health Care $593k–$62M
OrbiMed
VC Fund
11 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Pharmaceutical $9.8M–$160M
TRANGELS
VC Fund
10 Turkey, United States, Estonia Seed, Pre-Seed, Angel Software, Information Technology, Artificial Intelligence $55k–$1.4M
FutuRx
VC Fund
10 Israel Seed, Venture - Series Unknown Biotechnology, Biopharma, Therapeutics
Docor International Management
VC Fund
9 Israel, United States Series C, Venture - Series Unknown Health Care, Biotechnology, Medical Device $8M–$22M
aMoon Fund
VC Fund
8 United States, Israel, France Series B, Series A, Series C Health Care, Biotechnology, Medical $5.7M–$93M
Welltech Ventures
VC Fund
7 Israel, United States, Poland Seed, Series A, Venture - Series Unknown Health Care, Artificial Intelligence, mHealth $718k–$20M
HBL Hadasit Bio Holdings
VC Fund
7 Israel Venture - Series Unknown, Seed, Series A Biotechnology, Medical, Health Care $10M–$47M
RMGP Biopharma Investment Fund
VC Fund
7 Israel Seed, Series B, Venture - Series Unknown Biotechnology, Biopharma, Therapeutics
ZORA Ventures
VC Fund
7 Israel, United States, United Kingdom Seed, Series A, Convertible Note Biotechnology, Health Care, Software $1M–$8.6M
S2G Investments
VC Fund
6 United States, Canada, Israel Series A, Series B, Venture - Series Unknown Food and Beverage, Agriculture, Biotechnology $3.9M–$100M
Arkin Holdings
VC Fund
6 Israel, United States, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$95M
Egypt Ventures
VC Fund
6 Egypt, United States, The Netherlands Seed, Venture - Series Unknown, Pre-Seed Software, Information Technology, FinTech $28k–$120M
Candan Karabagli
Angel
5 Turkey Seed, Angel, Series A Biotechnology, Analytics, Biopharma $280k–$1.1M
iVentures Asia
VC Fund
5 Israel, United States, Hong Kong Series A, Convertible Note, Seed Software, Biotechnology, Mobile $820k–$5.5M
Agriline
VC Fund
5 Israel Seed, Series A, Venture - Series Unknown Health Care, Medical, Biotechnology $1.3M–$17M
Sapir Venture Partners
VC Fund
5 Israel, United States, United Kingdom Seed, Pre-Seed, Series A Software, Biotechnology, Analytics $305k–$40M
Istcapital
VC Fund
5 Turkey, United States, United Kingdom Seed, Series A Artificial Intelligence, Biotechnology, SaaS $230k–$10M
Milk & Honey Ventures
VC Fund
5 Israel Pre-Seed, Seed, Series A Food and Beverage, Biotechnology, Nutrition $1M–$5.2M
Siddhi Capital
VC Fund
5 United States, Israel, Canada Seed, Series A, Pre-Seed Food and Beverage, Biotechnology, AgTech $1M–$21M
ALIVE Israel HealthTech Fund
VC Fund
5 Israel, United States Series A, Series B, Series C Health Care, Biotechnology, Medical Device $4.4M–$55M
Kinisis Ventures
VC Fund
5 Cyprus, United States, United Kingdom Seed, Venture - Series Unknown, Pre-Seed Manufacturing, Energy, 3D Technology $218k–$2.6M
Diffusion Capital Partners
VC Fund
5 Turkey, United States, United Kingdom Seed, Pre-Seed Software, Information Technology, SaaS $59k–$3M
iAngels
VC Fund
5 United States, Israel, United Kingdom Seed, Series A, Pre-Seed Artificial Intelligence, Software, Financial Services $120k–$22M
Consensus Business Group
VC Fund
5 Israel, United States, United Kingdom Series B, Seed Health Care, Medical Device, Medical $1.3M–$80M
New York Ventures
VC Fund
4 United States, Canada, Israel Seed, Series A, Series B Health Care, Biotechnology, Software $1M–$53M
South Israel Bridging Fund
VC Fund
4 Israel, Cyprus, United States Series A, Venture - Series Unknown, Series B Biotechnology, Software, Energy $750k–$34M
GlenRock Israel
VC Fund
4 Israel, United States Seed, Series A, Series B Software, Health Care, Cyber Security $100k–$30M
Johnson & Johnson Robotics and Digital Solutions
VC Fund
4 United States, Israel, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $300k–$100M
Cancer Focus Fund
VC Fund
4 Israel, United States, Germany Venture - Series Unknown, Series A, Seed Biotechnology, Medical, Health Care $4.5M–$47M
Entrée Capital
VC Fund
4 Israel, United States, United Kingdom Seed, Series A, Series B Software, FinTech, Financial Services $1.5M–$54M
Clal Biotechnology Industries
VC Fund
4 Israel, United States Series A, Series B Health Care, Biotechnology, Medical Device $4M–$55M
Millenium Food-Tech
VC Fund
4 Israel Seed, Series A, Series B Food and Beverage, Manufacturing, Retail $2.5M–$105M
Integra Holdings
VC Fund
4 Israel Seed, Series B, Series F Biotechnology, Pharmaceutical, Life Science
Tnuva
VC Fund
4 Israel Seed, Series A, Series B Biotechnology, Food and Beverage, Food Processing $1.2M–$6M
Takeda Ventures
VC Fund
4 United States, United Kingdom, Israel Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $12M–$130M
fresh.fund
VC Fund
4 Israel, United States, Norway Seed, Pre-Seed, Series A Artificial Intelligence, Software, Health Care $300k–$21M
Grove Ventures
VC Fund
4 Israel, United States Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $3.3M–$74M
Ziegler Meditech Equity Partners
VC Fund
3 United States, Israel Series C, Series E, Series F Health Care, Biotechnology, Mobile
Ömer Aras
Angel
3 Turkey Seed, Angel Retail, Biopharma, Marketing $280k–$4M
ACT Venture Partners
VC Fund
3 Turkey, United States, United Kingdom Seed, Series A, Convertible Note Software, Artificial Intelligence, Biotechnology $345k–$9.5M
PeakBridge
VC Fund
3 Israel, United States, United Kingdom Series A, Seed, Series B Food and Beverage, Health Care, Food Processing $501k–$50M
CPT Capital
VC Fund
3 United States, Israel, United Kingdom Seed, Series A, Series B Food and Beverage, Biotechnology, Food Processing $1.3M–$226M
Tyson Ventures
VC Fund
3 United States, Israel Grant, Series A Food and Beverage, Biotechnology, Software $4M–$37M
M Ventures
VC Fund
3 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
M. Cengiz Aydın
Angel
3 Turkey Seed, Angel Biopharma, Biotechnology
Binder & Partners Ventures
VC Fund
3 Israel, France, United States Seed, Pre-Seed, Series A Software, Information Technology, Computer $2M–$14M
Access all 50 investors in Middle East Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Trendlines Group
VC Fund · Misgav, HaZafon, Israel · 21 investments in Middle East Biotechnology startups

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Venture - Series Unknown
  • Geography: Israel, Singapore, United Kingdom

Investor stats

  • Total investments: 70
  • Round size: Seed $650k–$4.1M; Venture - Series Unknown $1M–$62M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Show all investments...

Israel Innovation Authority
VC Fund · Jerusalem, Yerushalayim, Israel · 18 investments in Middle East Biotechnology startups

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Biotechnology
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Israel, United States, Mali

Investor stats

  • Total investments: 217
  • Round size: Seed $400k–$6M; Grant $130k–$3.5M; Pre-Seed $100k–$2.1M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $10M in 2023

Portfolio highlights

  • Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
  • PulseNmore — Pulsenmore (TASE:PULS) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening.
  • GeoRank Studio — GeoRank Studio is a specialist SEO, Generative Engine Optimisation (GEO), and Reputation Management agency helping businesses across the UK, EU, and US gain visibility in both traditional and AI-powered search.As AI search engines including ChatGPT, Perplexity, and Google AI Overviews now answer a growing share of commercial queries without aclick, GeoRank Studio helps businesses adapt. We implement the technical and content changes needed to get brands cited in AI-generated answers — a discipline known as Generative Engine Optimisation or GEO.Our core services include technical SEO audits and full implementation, GEO optimisation including FAQPage schema markup, entity optimisation, and AI crawler configuration, reputation management including review removal from Google and Trustpilot, negative SERP suppression, and monthly AI citation tracking reports.GeoRank Studio was founded in 2022 and operates fully remotely, serving clients in professional services, SaaS, hospitality, luxury retail, and e-commerce. All packages include a 14-day money-back guarantee.Official Website: georankstudio.com
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 16 investments in Middle East Biotechnology startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 122
  • Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $22M–$101M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2020

Portfolio highlights

  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • Crystalys Therapeutics — Transforming care for people living with gout.
  • Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Show all investments...

OurCrowd
VC Fund · Jerusalem, Yerushalayim, Israel · 16 investments in Middle East Biotechnology startups

Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series B, Series A, Seed
  • Geography: Israel, United States, New Zealand

Investor stats

  • Total investments: 387
  • Round size: Seed $593k–$8M; Series A $3M–$22M; Series B $6.3M–$62M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely actively investing — fresh fund, raised $230k in 2026

Portfolio highlights

  • N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
  • Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
  • MUV Interactive — MUV Interactive designs and develops innovative technology for active human sensing, providing a natural and fluent interactive experience with any type of digital application, from displayed content, and smart home appliances to IOT (Internet of Things) devices, drones and AR/VR applications. The company’s flagship product, Bird, is anintuitive device that is worn on the index finger, which transforms any space into a 3D Interactive Environment. Bird is the first device to integrate the entire spectrum of input and control methods – including touch, remote touch, gesture control and mouse functionality. This gives users the flexibility to interact with each type of digital content in the most intuitive way, whether up close or from a distance of up to 100 feet away.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 11 investments in Middle East Biotechnology startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 762
  • Round size: Series A $9.8M–$116M; Series B $23M–$148M; Series C $19M–$160M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely actively investing — fresh fund, raised $192M in 2026

Portfolio highlights

  • CoGenesys — CoGenesys is a biopharmaceutical company focused on the development of peptide- and protein-based medicines. The company develops peptide and protein-based medicines for cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases.
  • InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
  • Bonovo Orthopedics —
Show all investments...

TRANGELS
VC Fund · Istanbul, Istanbul, Turkey · 10 investments in Middle East Biotechnology startups

Early Stage Investment Fund and Network

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Angel
  • Geography: Turkey, United States, Estonia

Investor stats

  • Total investments: 60
  • Round size: Seed $67k–$1.4M; Angel $100k–$500k; Pre-Seed $55k–$500k
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Datasance — Securely deploy, manage, and scale containerized workloads across thousands of heterogeneous far-edge and IoT environments.
  • Trawell Data — Trawell Data is a mobile data services company that provides travelers to use mobile data on their mobile phones without changing phones or sim cards. It enables the phone to digitally connect and use the local operator. Trawell Data was established in 2015 and is headquartered in Syosset, New York.
  • Visionteractive — Visionteractive develops social media based, fun and interactive physical and digital products, bridging the gap between online and actual world. The company aims to bring a brand together with the target audience by developing various creative products, while enhancing the memorability owing to the interactive experience with the users.Visionteractive was founded on 2013 and is based in Turkey.
Show all investments...

FutuRx
VC Fund · Ness Ziona, HaMerkaz, Israel · 10 investments in Middle East Biotechnology startups

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Therapeutics
  • Stage:Seed, Venture - Series Unknown
  • Geography: Israel

Investor stats

  • Total investments: 10
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • A2i Therapeutics — A2i Therapeutics develops novel therapeutic modulators of the protein that helps to control the immune response and neurological disorders.
  • Skip Therapeutics — Skip Therapeutics develops precision, RNA-based, treatments for rare genetic diseases. Millions of people worldwide are affected by thousands of rare genetic disorders, yet the limited patient populations, further divided by patient-specific mutations, have hampered the discovery of effective treatments. Recent developments in RNA-therapeuticsprovide an enlarged molecular toolkit that can be used quickly and affordably to repair damaged genes' ability to make proteins. Computational techniques could be used to help identify sub-patient populations that would be eligible for treatment with RNA-based therapeutics and match molecular therapy options across the large landscape of known disease-causing mutations.
  • Selene Therapeutics — Selene Therapeutics is developing a new therapeutic strategy for treating refractory epilepsy by the regulation of the neuronal activity set point by a reduction of the neuronal mean firing rate (MFR).Selene aims to develop small molecule inhibitors of Dihydroorotate dehydrogenase (DHODH), a mitochondrial enzyme located on the inner mitochondrialmembrane and participating in several key cellular homeostatic processes.
Show all investments...

Docor International Management
VC Fund · Tel Aviv, Tel Aviv, Israel · 9 investments in Middle East Biotechnology startups

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series C, Venture - Series Unknown
  • Geography: Israel, United States

Investor stats

  • Total investments: 18
  • Round size: Series C $13M–$22M; Venture - Series Unknown $8M–$15M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
  • SP Nano — SP Nano is a nanotechnology company commercializing the use of nano-particles in the rapidly growing $106 billion composites market. The most widely-used type of composite consists of layers of fabric (carbon-fiber, glass-fiber, aramid) held together by a resin matrix. The matrix is the materials' weakest link - much weaker than the layersof fibers it binds. When composite structures and components commonly used in the aerospace, defense, automotive, marine and sporting goods industries fail, it's often because of this large discrepancy in strength between the fibers and the resin.
  • Raziel Therapeutics — Raziel's drug aims for fat melting by harnessing the body’s own natural healing power and delivering proven biological activity.
Show all investments...

aMoon Fund
VC Fund · Ra'anana, HaMerkaz, Israel · 8 investments in Middle East Biotechnology startups

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 80
  • Round size: Series A $5.7M–$82M; Series B $22M–$93M; Series C $30M–$82M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: Likely still investing — raised $340M in 2022

Portfolio highlights

  • Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
  • Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
  • Hopscotch Primary Care — We provide primary care services to seniors on Medicare, offering more time with your doctor, and a full care team to support all of your healthcare needs.
Show all investments...

Welltech Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 7 investments in Middle East Biotechnology startups

Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, mHealth
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Israel, United States, Poland

Investor stats

  • Total investments: 23
  • Round size: Seed $718k–$19M; Series A $6M–$20M; Venture - Series Unknown $3M–$5.3M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • MDI Health — Transform Quality Metrics Clinical Outcomes & Costs all inOne Platform. Your AI Co-Pilot for Medication Management
  • Antidote Health — AntidoteHealth.ai offers primary care on its telehealth app on a 24/7 basis, including prescriptions & more. Book your appointment today!
  • Marquee — Marquee turns football data into decision-ready insights in seconds, unifying external and internal data and filtering it through your club's sporting DNA.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
HBL Hadasit Bio Holdings
VC Fund · Jerusalem, Yerushalayim, Israel · 7 investments in Middle East Biotechnology startups

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: Israel

Investor stats

  • Total investments: 11
  • Round size: Venture - Series Unknown $10M–$47M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Show all investments...

RMGP Biopharma Investment Fund
VC Fund · 7 investments in Middle East Biotechnology startups

RMGP Biopharma Investment Fund is an investment Fund

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Therapeutics
  • Stage:Seed, Series B, Venture - Series Unknown
  • Geography: Israel

Investor stats

  • Total investments: 8
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Circuit-Bio — Circuit-Bio is a synthetic biology company developing a unique platform of logical gene circuits for cancer immunotherapy. The platform used by the company focuses on creating gene circuits that can precisely and locally manufacture a combination of several immune-stimulating proteins (immunomodulators) that are only expressed in specific tumorcells. The circuit turns cancer cells into "Trojan horses" that are used as anti-tumor resources and incite a potent, long-lasting immune response.
  • Skip Therapeutics — Skip Therapeutics develops precision, RNA-based, treatments for rare genetic diseases. Millions of people worldwide are affected by thousands of rare genetic disorders, yet the limited patient populations, further divided by patient-specific mutations, have hampered the discovery of effective treatments. Recent developments in RNA-therapeuticsprovide an enlarged molecular toolkit that can be used quickly and affordably to repair damaged genes' ability to make proteins. Computational techniques could be used to help identify sub-patient populations that would be eligible for treatment with RNA-based therapeutics and match molecular therapy options across the large landscape of known disease-causing mutations.
  • Selene Therapeutics — Selene Therapeutics is developing a new therapeutic strategy for treating refractory epilepsy by the regulation of the neuronal activity set point by a reduction of the neuronal mean firing rate (MFR).Selene aims to develop small molecule inhibitors of Dihydroorotate dehydrogenase (DHODH), a mitochondrial enzyme located on the inner mitochondrialmembrane and participating in several key cellular homeostatic processes.
Show all investments...

ZORA Ventures
VC Fund · Herzliya, Tel Aviv, Israel · 7 investments in Middle East Biotechnology startups

Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Convertible Note
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 17
  • Round size: Seed $1M–$8.6M; Series A $4M–$8.1M
  • Lead/follow: 6% lead, 94% follow
  • Last fund: May invest from a new fund soon — raised $740k in 2020

Portfolio highlights

  • Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
  • WeedOut — WeedOut: Exploiting Sterility against Resistant Weeds
  • Earth Force Technologies — Earth Force is a Vegetation Management System platform.
Show all investments...

S2G Investments
VC Fund · Chicago, Illinois, United States · 6 investments in Middle East Biotechnology startups, 16 in the past 12 months

S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.

Show more...

Investment focus

  • Industry: Food and Beverage, Agriculture, Biotechnology
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 229
  • Round size: Series A $4M–$55M; Series B $3.9M–$100M; Venture - Series Unknown $4.3M–$100M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely actively investing — fresh fund, raised $1B in 2026

Portfolio highlights

  • Kanin Energy — Our solution transforms industrial waste heat into clean baseload electricity, boosting energy efficiency, cutting costs, improving reliability, and lowering
  • Corvus Robotics — Autonomous inventory intelligence for the physical economy. Corvus Robotics drones and AI forklift sensors count inventory in Fortune 500 warehouses.
  • Energy Vault — Energy Vault creates gravity and kinetic energy-based, long-duration energy storage solutions that are transforming the world's approach to energy storage.
Show all investments...

Arkin Holdings
VC Fund · Herzliya, Tel Aviv, Israel · 6 investments in Middle East Biotechnology startups

Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: Israel, United States, Switzerland

Investor stats

  • Total investments: 32
  • Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely actively investing — fresh fund, raised $100M in 2026

Portfolio highlights

  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
  • Werewolf Therapeutics — Developing transformative conditionally activated proinflammatory immune modulating medicines to unleash a powerful attack on cancer.
Show all investments...

Egypt Ventures
VC Fund · El Cairo, Valle del Cauca, Colombia · 6 investments in Middle East Biotechnology startups

Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.

Show more...

Investment focus

  • Industry: Software, Information Technology, FinTech
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Egypt, United States, The Netherlands

Investor stats

  • Total investments: 38
  • Round size: Seed $250k–$3M; Pre-Seed $28k–$2M; Venture - Series Unknown $3.2M–$120M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • Flend — Egypt’s first tech enabled, data driven financing solutions platform dedicated to small businesses.
  • D OCC Hub — Smart Incident Management Solutions
  • InfiniLink — Empowering Hyperscale Datacenters Building Energy-Efficient Ultra-High-Speed Connectivity Solutions
Show all investments...

Candan Karabagli
Angel · The Hague, Zuid-Holland, The Netherlands · 5 investments in Middle East Biotechnology startups

Candan Karabagli - Yönetim Kurulu Başkanı, CHAIRMAN @ GS Yuasa

Show more...

Investment focus

  • Industry: Biotechnology, Analytics, Biopharma
  • Stage:Seed, Angel, Series A
  • Geography: Turkey

Investor stats

  • Total investments: 6
  • Round size: Seed $280k–$1.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Biolive — BIOLIVE was founded as a start-up company in Incubation Centre at Istanbul Technical University in 2016. The company transitioned to becoming a corporation with an investment from Vestel Ventures, a subsidiary of Zorlu Holding in 2017. Currently, the company produces bioplastic raw materials such as Bio-PE, Bio-PP, and Bio-ABS in scale-up andnext-gen materials such as plant-based leather and also offers sustainable solutions.
  • Vispera — Drive your retail execution to perfection with Vispera image recognition technologies and intelligent retail solutions.
  • PhiTech Bioinformatics — PhiTech pioneers the integration of DNA & RNA sequencing data with AI for rare disease diagnostics. We offer the first RNA-based diagnostic support tool.
Show all investments...

iVentures Asia
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 5 investments in Middle East Biotechnology startups

iVentures Asia is a Hong Kong-based venture capital fund that offers end-to-end support to their portfolio companies. The company was founded by Benjamin Weiss in November 2013.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Mobile
  • Stage:Series A, Convertible Note, Seed
  • Geography: Israel, United States, Hong Kong

Investor stats

  • Total investments: 21
  • Round size: Seed $2M–$2.4M; Series A $4M–$5.5M; Convertible Note $820k–$3M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • WeedOut — WeedOut: Exploiting Sterility against Resistant Weeds
  • DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
  • Vision Travel AI — Vision Travel AI is a groundbreaking platform based in China, dedicated to transforming the cultural tourism industry through the fusion of VR/AR technologies and artificial intelligence. By recreating historical scenes and providing immersive cultural experiences, Vision Travel AI allows tourists to explore and engage with history like neverbefore.Vision Travel AI utilizes virtual reality (VR) technology to create completely virtual environments. These environments transport tourists back in time, allowing them to experience historical scenes as if they were actually there. When tourists visit historical sites, they can use devices like smartphones or AR glasses to see reconstructions of ruins and historical landmarks. One of the standout features of Vision Travel AI is its interactive guide system, featuring the Guide BOT Digital Human. Upon entering a site, visitors can activate this digital guide to begin an "Ask and Answer Tour." The Guide BOT functions like a real tour guide, offering detailed introductions to artifacts, buildings, and historical contexts. Tourists can interrupt the Guide BOT at any time to ask questions, receiving instant, in-depth answers that expand their knowledge and understanding of the site. Vision Travel AI's innovative approach to cultural tourism transforms the way people connect with history. Vision Travel AI has established partnerships with over 7 historical and cultural sites globally, enhancing visitor experiences through cutting-edge technology. A significant collaboration with Sichuan Province's Dujiangyan Irrigation System, a UNESCO World Heritage site, has brought ancient Chinese engineering marvels to life for visitors through immersive VR/AR experiences.
Show all investments...

Agriline
VC Fund · Bromsgrove, Worcestershire, United Kingdom · 5 investments in Middle East Biotechnology startups

Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $1.3M–$7.5M; Series A $5M–$17M; Venture - Series Unknown $2.2M–$16M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
  • SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
Show all investments...

Sapir Venture Partners
VC Fund · 5 investments in Middle East Biotechnology startups

Early Stage VC

Show more...

Investment focus

  • Industry: Software, Biotechnology, Analytics
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 22
  • Round size: Seed $1.3M–$10M; Pre-Seed $305k–$800k; Series A $10M–$40M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
  • Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
  • DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Istcapital
VC Fund · Capelle Aan Den Ijssel, Zuid-Holland, The Netherlands · 5 investments in Middle East Biotechnology startups

ISTcapital is a family office-backed venture capital firm partnering with exceptional founders to build early-stage, global technology companies.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, SaaS
  • Stage:Seed, Series A
  • Geography: Turkey, United States, United Kingdom

Investor stats

  • Total investments: 15
  • Round size: Seed $230k–$3M; Series A $500k–$10M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Cellestetix — Cellestetix is a biotech company that specializes in developing and commercializing plant-based exosome formulas for regenerating skin, hair, and wellness.
  • Spline — Spline is a free 3D design software with real-time collaboration to create web interactive experiences in the browser. Easy 3d modeling, animation, textures, and more.
  • PhiTech Bioinformatics — PhiTech pioneers the integration of DNA & RNA sequencing data with AI for rare disease diagnostics. We offer the first RNA-based diagnostic support tool.
Show all investments...

Milk & Honey Ventures
VC Fund · 5 investments in Middle East Biotechnology startups

Tel-Aviv based investment firm, focused on the effective acceleration of disruptive New Protein technologies

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Nutrition
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Israel

Investor stats

  • Total investments: 6
  • Round size: Seed $3.5M–$5.2M; Pre-Seed $1M–$2.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
  • SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
  • Meala Foodtech — Revolutionary texturized plant proteins that replace eggs and hydrocolloids. Clean-label, allergen-free solutions for baking, savory foods, and dressings.
Show all investments...

Siddhi Capital
VC Fund · Cherry Hill, New Jersey, United States · 5 investments in Middle East Biotechnology startups

Siddhi Capital is the growth equity partner for convention-crushing food and beverage companies.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, AgTech
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 60
  • Round size: Seed $2M–$6.3M; Pre-Seed $1M–$3.6M; Series A $5M–$21M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely actively investing — fresh fund, raised $475k in 2026

Portfolio highlights

  • Nopalera — Vegan, cruelty free, and Latina owned. Handmade cactus products that celebrate culture and resilience.
  • Pigmentum — Pigmentum is an ag-tech firm developing a molecular technology platform that enables external gene activation in plants.
  • ProFuse Technology — ProFuse Technology revolutionizes cultured meat production by shortening it duration, improving the meat quality and increasing yields.
Show all investments...

ALIVE Israel HealthTech Fund
VC Fund · Tel Aviv, Tel Aviv, Israel · 5 investments in Middle East Biotechnology startups

ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B, Series C
  • Geography: Israel, United States

Investor stats

  • Total investments: 16
  • Round size: Series A $4.4M–$17M; Series B $22M–$30M; Series C $30M–$55M
  • Lead/follow: 69% lead, 31% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
  • UltraSight — UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere.
  • Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Show all investments...

Kinisis Ventures
VC Fund · New York, New York, United States · 5 investments in Middle East Biotechnology startups

Kinisis Ventures is a venture capital firm backing bold founders building the future. Discover our portfolio, meet our team, and explore how we support startups from seed to scale.

Show more...

Investment focus

  • Industry: Manufacturing, Energy, 3D Technology
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Cyprus, United States, United Kingdom

Investor stats

  • Total investments: 16
  • Round size: Seed $1.1M–$2.6M; Venture - Series Unknown $218k–$1.4M
  • Lead/follow: 63% lead, 37% follow

Portfolio highlights

  • Phase3D — Phase3D develops in-situ monitoring technology for additive manufacturing, providing real-time, layer-by-layer inspection of 3D printing processes. Their flagship product, Fringe, uses structured light to detect and quantify anomalies during printing, offering data in microns for quality assessment. Fringe is compatible with various industrial 3Dprinters and can be retrofitted to existing equipment. The system helps users identify issues early and take action to maintain part integrity.
  • Autonomics — Autonomics is developing a city cleaning solution to help municipalities make the urban environment a clean, healthy, and cozy place to live with robotics and AI.
  • ProMed BioSciences — Promed is an EU-based, highly innovative biotech company, developing collagen-based biomaterials
Show all investments...

Diffusion Capital Partners
VC Fund · Istanbul, Istanbul, Turkey · 5 investments in Middle East Biotechnology startups

Diffusion Capital Partners (DCP) is Turkey's leading Venture Capital fund manager with a focus on deep-tech opportunities.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Pre-Seed
  • Geography: Turkey, United States, United Kingdom

Investor stats

  • Total investments: 65
  • Round size: Seed $350k–$3M; Pre-Seed $59k–$1.4M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: May invest from a new fund soon — raised $35M in 2020

Portfolio highlights

  • BigOmics — Get robust and reproducible results in a few clicks with Omics Playground: your user-friendly Omics Data Analysis Software.
  • Etched — Transformers etched into silicon. By burning the transformer architecture into our chips, we're creating the world's most powerful servers for transformer inference.
  • GoWit Technology — Unlock your retail media potential with GoWit's omnichannel Retail Media Advertising platform. Expand your audience reach, optimize bidding, and leverage first-party data for maximum conversions and privacy protection.
Show all investments...

iAngels
VC Fund · Tel Aviv, Tel Aviv, Israel · 5 investments in Middle East Biotechnology startups

iAngels is a VC and angel investment platform that leverages due diligence and analytics to enable accredited investors around the world the ability to invest in early-stage technology deals in Israel.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Financial Services
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 139
  • Round size: Seed $900k–$10M; Pre-Seed $120k–$400k; Series A $4.2M–$22M
  • Lead/follow: 9% lead, 91% follow
  • Last fund: May invest from a new fund soon — raised $56M in 2021

Portfolio highlights

  • Nas Daily —
  • Recapp — Recapp is a sports-video platform that creates a single, scrollable feed by compiling and arranging game highlights from various leagues.
  • Lasso Security — Lasso Security defends the LLM frontier with advanced LLM Cybersecurity solutions. Embrace progress and strengthen your AI cybersecurity posture
Show all investments...

Consensus Business Group
VC Fund · London, England, United Kingdom · 5 investments in Middle East Biotechnology startups

Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series B, Seed
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 24
  • Round size: Seed $1.3M–$4.5M; Series B $11M–$80M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
  • Synchrony Medical — Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment.
  • Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Show all investments...

New York Ventures
VC Fund · New York, New York, United States · 4 investments in Middle East Biotechnology startups, 7 in the past 12 months

New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the RegionalEconomic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 158
  • Round size: Seed $1M–$6.2M; Series A $3M–$20M; Series B $4M–$53M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Fathom Therapeutics — The Molecular Frontier
  • CREW Carbon — CREW provides wastewater treatment facilities with a process intensification solution that improves performance, lowers costs, and permanently removes greenhouse gasses.
  • Fesarius Therapeutics — Intelligently Patterned Native-State Hydrogel Wound Dressing for Dermal Tissue Regeneration...
Show all investments...

South Israel Bridging Fund
VC Fund · Be'er Sheva, HaDarom, Israel · 4 investments in Middle East Biotechnology startups

South Israel Bridging Fund is a venture capital firm.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Energy
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: Israel, Cyprus, United States

Investor stats

  • Total investments: 23
  • Round size: Series A $1.5M–$34M; Series B $7M–$25M; Venture - Series Unknown $750k–$2M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2020

Portfolio highlights

  • Gadfin — Gadfin design and develops long-range Urgent-delivery systems of the future, which is no less than a game-changer for the Medical and Time-critical deliveries market. Its system brings together traditional flight knowledge, unmanned and autonomy technology, thus redefining delivery capabilities in terms of flight radius, safety, reliability, andautomation, that is going to disrupt the world.
  • Stargo — AI powered routing, pricing and payment solutions for the freight industry
  • Electriq Global — Electriq is a hydrogen carrier that acts like coffee powder for a coffee machine - simplifying storage, transport, and use of hydrogen in off-grid applications and long-term storage.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
GlenRock Israel
VC Fund · Herzliya, Tel Aviv, Israel · 4 investments in Middle East Biotechnology startups

A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.

Show more...

Investment focus

  • Industry: Software, Health Care, Cyber Security
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 37
  • Round size: Seed $1M–$9M; Series A $1.5M–$12M; Series B $100k–$30M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
  • MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
  • Quris — Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharmacompanies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.
Show all investments...

Johnson & Johnson Robotics and Digital Solutions
VC Fund · New Brunswick, New Jersey, United States · 4 investments in Middle East Biotechnology startups

Healthcare innovation wherever it originates.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 80
  • Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
  • Manus Neurodynamica — Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
  • Glyphic Biotechnologies — We sequence proteins. Glyphic Biotechnologies is decoding the human proteome through full coverage, de novo protein sequencing at single molecule resolution to enable the development of novel therapeutics and diagnostics and, ultimately, a deeper understanding of life itself.
Show all investments...

Cancer Focus Fund
VC Fund · Shreveport, Louisiana, United States · 4 investments in Middle East Biotechnology startups

Cancer Focus Fund is an oncology-focused investment firm advancing breakthrough cancer therapies by partnering with leading scientists, institutions and early-stage companies.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: Israel, United States, Germany

Investor stats

  • Total investments: 10
  • Round size: Series A $5.4M–$28M; Venture - Series Unknown $4.5M–$47M
  • Lead/follow: 60% lead, 40% follow
  • Last fund: Likely actively investing — fresh fund, raised $23M in 2025

Portfolio highlights

  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • March Biosciences — Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity of
  • Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
Show all investments...

Entrée Capital
VC Fund · London, England, United Kingdom · 4 investments in Middle East Biotechnology startups, 17 in the past 12 months

We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves.We back founders with a partnership built on trust, fairness and real operating experience. Westand with founders through every challenge, and help them grow with clarity, resilience and purpose.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 309
  • Round size: Seed $1.5M–$15M; Series A $5M–$30M; Series B $17M–$54M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely actively investing — fresh fund, raised $175M in 2025

Portfolio highlights

  • Chamelio — Chamelio builds intelligent technology for in-house legal teams. We understand that every in-house legal team operates uniquely - shaped by their industry context, company culture, and strategic priorities. Our platform adapts to these distinct characteristics, delivering hyper-personalized workflows that evolve with your team's specific needs.
  • Archy — SaaS Practice Management Software for Dental Practices
  • Lasso Security — Lasso Security defends the LLM frontier with advanced LLM Cybersecurity solutions. Embrace progress and strengthen your AI cybersecurity posture
Show all investments...

Clal Biotechnology Industries
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Middle East Biotechnology startups

Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 18
  • Round size: Series A $4M–$55M; Series B $15M–$40M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • TytoCare — TytoCare offers the Home Smart Clinic - for accessible, high-quality primary care from home, with no compromises.
  • Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
  • Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Show all investments...

Millenium Food-Tech
VC Fund · 4 investments in Middle East Biotechnology startups

Millennium Food-Tech is an R&D partnership traded on the Tel Aviv Stock Exchange that specializes in investment in and betterment of companies in food-tech sectors,. Millennium seeks to invest in companies that specialize in identifying and developing innovative, and transformative ideas in the food, drinks, and nutrition industry. Millenniumhas experienced management, proven solutions, and a supportive network to develop ideas and start-ups from early-stage to maturity to exit.

Show more...

Investment focus

  • Industry: Food and Beverage, Manufacturing, Retail
  • Stage:Seed, Series A, Series B
  • Geography: Israel

Investor stats

  • Total investments: 20
  • Round size: Seed $2.5M–$6M; Series A $3M–$15M; Series B $17M–$105M
  • Lead/follow: 65% lead, 35% follow

Portfolio highlights

  • TripleW Group NV — Making Waste History. TripleW upcycles food waste into high-value bioplastic
  • ansā — Ansā is a coffee roasting solution designed specifically for the workplace. It offers a system that enables organizations to roast coffee on-site. The solution focuses on providing fresh coffee tailored to workplace preferences. The industries served include food service and hospitality.
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
Show all investments...

Integra Holdings
VC Fund · Wallisellen, Zurich, Switzerland · 4 investments in Middle East Biotechnology startups

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Life Science
  • Stage:Seed, Series B, Series F
  • Geography: Israel

Investor stats

  • Total investments: 8
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
  • Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
  • Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Show all investments...

Tnuva
VC Fund · Glil Yam, Tel Aviv, Israel · 4 investments in Middle East Biotechnology startups

On the Tnuva website you will find information about the Company, its subsidiaries, press releases, the Program for Better Nutrition, contacting customer service and more.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Food Processing
  • Stage:Seed, Series A, Series B
  • Geography: Israel

Investor stats

  • Total investments: 6
  • Round size: Seed $1.2M–$6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Pigmentum — Pigmentum is an ag-tech firm developing a molecular technology platform that enables external gene activation in plants.
  • Ever After Foods — We produce slaughter-free meats that prevent animal cruelty, and support health, security and sustainability for our planet and its people.
  • ProFuse Technology — ProFuse Technology revolutionizes cultured meat production by shortening it duration, improving the meat quality and increasing yields.
Show all investments...

Takeda Ventures
VC Fund · San Diego, California, United States · 4 investments in Middle East Biotechnology startups

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 104
  • Round size: Series A $12M–$58M; Series B $20M–$130M; Series C $30M–$115M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
  • Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
  • Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Show all investments...

fresh.fund
VC Fund · Jerusalem, Yerushalayim, Israel · 4 investments in Middle East Biotechnology startups, 7 in the past 12 months

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, Norway

Investor stats

  • Total investments: 44
  • Round size: Seed $1.6M–$10M; Pre-Seed $300k–$6M; Series A $11M–$21M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: Likely actively investing — fresh fund, raised $7.9M in 2025

Portfolio highlights

  • Kimba — Kimba is an adaptive scent sleep system that uses sleep and biometric data to deliver personalized, natural-origin scents at specific moments throughout the night, designed to actively improve sleep rather than simply track it.
  • CopilotKit — The Enterprise-Ready Frontend Stack for Agents. CopilotKit lets you integrate LLMs or agents with real-time context, UI control, and full flexibility.
  • Shifters AI — Shifters builds autonomous robotic teams for dangerous ground missions.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Grove Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Middle East Biotechnology startups, 10 in the past 12 months

Grove Ventures is a leading early-stage venture capital fund in Israel. It partners with seed and early-stage founders

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 76
  • Round size: Seed $3.3M–$20M; Series A $8M–$50M; Series B $22M–$74M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $1.5M in 2024

Portfolio highlights

  • Particula — Particula brings new life into Rubik's cube, dice, and chess using AI, connectivity, and interactivity. Enter a smart games world with modern versions of classics!
  • LimitlessCNC — Limitless CNC is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM agent that works with NX-CAM to give industry-specific strategies and operations.
  • FormX — California's trusted sustainable builders. FormX delivers fully customized single-family homes, ADUs, and backyard offices built faster with component-based modular construction.
Show all investments...

Ziegler Meditech Equity Partners
VC Fund · Milwaukee, Wisconsin, United States · 3 investments in Middle East Biotechnology startups

Ziegler is a privately held investment bank, capital markets and proprietary investments firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Mobile
  • Stage:Series C, Series E, Series F
  • Geography: United States, Israel

Investor stats

  • Total investments: 6
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
  • MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
  • MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
Show all investments...

Ömer Aras
Angel · Istanbul, Istanbul, Turkey · 3 investments in Middle East Biotechnology startups

Ömer Aras

Show more...

Investment focus

  • Industry: Retail, Biopharma, Marketing
  • Stage:Seed, Angel
  • Geography: Turkey

Investor stats

  • Total investments: 7
  • Round size: Seed $280k–$4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • LIVAD Technologies — LIVAD develops cutting edge Livestream Advertising products connecting brands with streamers. Our technology enables brands to serve smart, elegant, and non-intrusive ads while allowing streamers of all sizes to monetize their content consistently.
  • Getmobil — Getmobill offers services in refurbished devices and their sale and resale.
  • PhiTech Bioinformatics — PhiTech pioneers the integration of DNA & RNA sequencing data with AI for rare disease diagnostics. We offer the first RNA-based diagnostic support tool.
Show all investments...

ACT Venture Partners
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 3 investments in Middle East Biotechnology startups

Early stage deep tech investor

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Seed, Series A, Convertible Note
  • Geography: Turkey, United States, United Kingdom

Investor stats

  • Total investments: 42
  • Round size: Seed $345k–$3.2M; Series A $2.4M–$9.5M; Convertible Note $987k–$1.3M
  • Lead/follow: 69% lead, 31% follow
  • Last fund: May invest from a new fund soon — raised $29M in 2015

Portfolio highlights

  • NxLite — 3E Nano has developed and is commercializing a low cost, thermally and optically smart, Diamond-Like Carbon (DLC) coating. This nano thin film applied to glass and other transparent media is targeted toward windows, windshields, greenhouses, and solar module manufacturers.
  • Qubitrium — We offer advanced quantum technology solutions in cryptography, communication, and sensing. We develop and produce cutting-edge quantum products and provide services to integrate these technologies into industrial organizations.
  • Cellbricks Therapeutics — Cellbricks offers plastic surgery and transplant medicine that rely on artificial materials devoid of physiological functions or immunosuppressive transplants from human and animal sources. It offers the bio-fabrication of human tissue and organs, a widespread medical procedure that enables people to live longer and in better condition.
Show all investments...

PeakBridge
VC Fund · Valletta, NA - Malta, Malta · 3 investments in Middle East Biotechnology startups

PeakBridge is a highly networked, global impact VC that funds and connects the people, technology and processes that will shape the future of food. We invest in visionary pioneers, from early stage to Series A-B, with scalable, protectable climate and health-focused technologies. At their core: a deep commitment to disrupting our food system whiledriving positive impact. Our team is spread across seven countries and includes pioneers of FoodTech investment and decades of deep Agri-Food operational and financial experience. Together, we create exceptional value for bold FoodTech entrepreneurs and investors. A member of the Edmond de Rothschild Private Equity partnership, PeakBridge is also the only venture capital firm that is an official partner of the world’s largest Agri-Food innovation initiative, EIT Food.

Show more...

Investment focus

  • Industry: Food and Beverage, Health Care, Food Processing
  • Stage:Series A, Seed, Series B
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 56
  • Round size: Seed $501k–$11M; Series A $4.5M–$17M; Series B $11M–$50M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: Likely still investing — raised $106M in 2022

Portfolio highlights

  • Myota — Precision prebiotic products developed by gut microbiome scientists. Clinically proven to improve your mental and physical health, and patented.
  • Ilant Health — We offer a comprehensive solution that take the stress and stigma out of obesity treatment. We increase access, improve quality, and drive reduction in total cost of care.
  • KÄÄPÄ Biotech — Medicinal mushrooms, biotechnology, mycology, forestry, agroforestry, and food production.
Show all investments...

CPT Capital
VC Fund · London, England, United Kingdom · 3 investments in Middle East Biotechnology startups

Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Food Processing
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 63
  • Round size: Seed $1.3M–$7M; Series A $6M–$50M; Series B $16M–$226M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
  • Xias Bio — Mitigate risk with flexible licensing options. Partner with us to transform your ideas into high-performance innovations optimized for efficacy and differentiation.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Show all investments...

Tyson Ventures
VC Fund · Springdale, Arkansas, United States · 3 investments in Middle East Biotechnology startups

Tyson Ventures is the investment arm of Tyson Foods. We aim to be the strategic partner of choice for disruptive innovators transforming the food industry, and provide sustainable nutrition to a growing global population. Our current areas of interest focus on emerging proteins, technology enablers and sustainability. Let’s build the future offood... together.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Software
  • Stage:Grant, Series A
  • Geography: United States, Israel

Investor stats

  • Total investments: 40
  • Round size: Series A $4M–$37M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $150M in 2016

Portfolio highlights

  • Athian — Funding livestock sustainability via a connected carbon marketplace.
  • Orderful — Gain full control to onboard, manage and resolve all of your EDI trading partner relationships and transactions in real-time.
  • Pactum — Pactum autonomous negotiations help companies unlock hidden value. Our AI negotiates non-strategic supplier contracts on a massive scale.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 3 investments in Middle East Biotechnology startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 188
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$50M; Series B $13M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • TwoStep Therapeutics — TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
  • Polaris Electro-Optics — Polaris Electro-Optics empowers integrated photonics for communications and computation.
Show all investments...

M. Cengiz Aydın
Angel · Istanbul, Istanbul, Turkey · 3 investments in Middle East Biotechnology startups

M. Cengiz Aydın

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology
  • Stage:Seed, Angel
  • Geography: Turkey

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PhiTech Bioinformatics — PhiTech pioneers the integration of DNA & RNA sequencing data with AI for rare disease diagnostics. We offer the first RNA-based diagnostic support tool.
Show all investments...

Binder & Partners Ventures
VC Fund · Paris, Ile-de-France, France · 3 investments in Middle East Biotechnology startups

Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.

Show more...

Investment focus

  • Industry: Software, Information Technology, Computer
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, France, United States

Investor stats

  • Total investments: 16
  • Round size: Seed $2M–$5M; Series A $8M–$14M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Acsense — The enterprise IAM Resilience Platform offering backup and recovery to reduce the risk of downtime, maintain data integrity, and deliver seamless access.
  • CYREBRO — CYREBRO is your online centralized interactive SOC platform that integrates all your security events with strategic monitoring, threat intelligence and IR
  • Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Investors in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 investors investing in Middle East Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists